Arrowhead Pharmaceuticals Stock Price

2.37 (4.33%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Arrowhead Pharmaceuticals Inc ARWR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
2.37 4.33% 57.11 11:36:37
Close Price Low Price High Price Open Price Previous Close
54.4213 57.70 54.79 54.74
Bid Price Ask Price Spread News
57.00 57.19 0.19 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
8,715 863,754 $ 56.44 $ 48,753,985 2,148,763 19.5101 - 74.40
Last Trade Time Type Quantity Stock Price Currency
11:36:42 13 $ 57.0497 USD

Arrowhead Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.84B 102.29M 74.24M $ 168.80M $ -75.87M 0.69 -76.99
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 6.00%

more financials information »

Arrowhead Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARWR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week46.2757.7044.2949.921,909,55610.8423.43%
1 Month43.6057.7042.4047.061,207,42313.5130.99%
3 Months45.7757.7032.8644.401,490,58911.3424.78%
6 Months37.7257.7030.8341.801,301,47719.3951.41%
1 Year36.3774.4019.510145.591,636,43920.7457.03%
3 Years3.8874.403.0125.541,699,26153.231,371.91%
5 Years5.2074.401.2019.541,405,98651.91998.27%

Arrowhead Pharmaceuticals Description

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Your Recent History
Arrowhead ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.